Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 1
1965 3
1966 2
1967 1
1969 1
1970 2
1971 1
1974 1
1991 1
1992 2
1993 1
1994 1
1995 4
1996 5
1997 7
1998 4
1999 3
2000 4
2001 4
2002 4
2003 8
2004 8
2005 11
2006 9
2007 7
2008 12
2009 8
2010 10
2011 14
2012 13
2013 12
2014 12
2015 9
2016 14
2017 21
2018 17
2019 12
2020 12
2021 19
2022 19
2023 19
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T. Brix SR, et al. Among authors: nitschke m. Kidney Int. 2018 Dec;94(6):1177-1188. doi: 10.1016/j.kint.2018.07.020. Epub 2018 Oct 29. Kidney Int. 2018. PMID: 30385041 Free article.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Gremlin 1+ fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues.
Kapoor VN, Müller S, Keerthivasan S, Brown M, Chalouni C, Storm EE, Castiglioni A, Lane R, Nitschke M, Dominguez CX, Astarita JL, Krishnamurty AT, Carbone CB, Senbabaoglu Y, Wang AW, Wu X, Cremasco V, Roose-Girma M, Tam L, Doerr J, Chen MZ, Lee WP, Modrusan Z, Yang YA, Bourgon R, Sandoval W, Shaw AS, de Sauvage FJ, Mellman I, Moussion C, Turley SJ. Kapoor VN, et al. Among authors: nitschke m. Nat Immunol. 2021 May;22(5):571-585. doi: 10.1038/s41590-021-00920-6. Epub 2021 Apr 26. Nat Immunol. 2021. PMID: 33903764
An Indo-Pacific coral spawning database.
Baird AH, Guest JR, Edwards AJ, Bauman AG, Bouwmeester J, Mera H, Abrego D, Alvarez-Noriega M, Babcock RC, Barbosa MB, Bonito V, Burt J, Cabaitan PC, Chang CF, Chavanich S, Chen CA, Chen CJ, Chen WJ, Chung FC, Connolly SR, Cumbo VR, Dornelas M, Doropoulos C, Eyal G, Eyal-Shaham L, Fadli N, Figueiredo J, Flot JF, Gan SH, Gomez E, Graham EM, Grinblat M, Gutiérrez-Isaza N, Harii S, Harrison PL, Hatta M, Ho NAJ, Hoarau G, Hoogenboom M, Howells EJ, Iguchi A, Isomura N, Jamodiong EA, Jandang S, Keyse J, Kitanobo S, Kongjandtre N, Kuo CY, Ligson C, Lin CH, Low J, Loya Y, Maboloc EA, Madin JS, Mezaki T, Min C, Morita M, Moya A, Neo SH, Nitschke MR, Nojima S, Nozawa Y, Piromvaragorn S, Plathong S, Puill-Stephan E, Quigley K, Ramirez-Portilla C, Ricardo G, Sakai K, Sampayo E, Shlesinger T, Sikim L, Simpson C, Sims CA, Sinniger F, Spiji DA, Tabalanza T, Tan CH, Terraneo TI, Torda G, True J, Tun K, Vicentuan K, Viyakarn V, Waheed Z, Ward S, Willis B, Woods RM, Woolsey ES, Yamamoto HH, Yusuf S. Baird AH, et al. Among authors: nitschke mr. Sci Data. 2021 Jan 29;8(1):35. doi: 10.1038/s41597-020-00793-8. Sci Data. 2021. PMID: 33514754 Free PMC article.
Extracorporeal membrane oxygenation in ANCA-associated vasculitis.
Arnold S, Deja M, Nitschke M, Bohnet S, Wallis S, Humrich JY, Riemekasten G, Steinhoff J, Lamprecht P. Arnold S, et al. Among authors: nitschke m. Autoimmun Rev. 2021 Jan;20(1):102702. doi: 10.1016/j.autrev.2020.102702. Epub 2020 Nov 11. Autoimmun Rev. 2021. PMID: 33188916 No abstract available.
289 results